NEOGENOMICS INC — Director's Dealing 2025

May 7, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2025-05-05

Reporting Person: Gunn Neil (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-05-05	Common Stock	P	4510.31	$7.755	Acquired	15846.31	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$14.82	2033-08-10	Common Stock (8353)	8353	Direct
Stock Option (Right to Buy)	$13.71	2034-06-01	Common Stock (8672)	8672	Direct
Restricted Stock Unit	$0		Common Stock (12254)	12254	Direct

Footnotes

F1: Once vested, the shares of common stock are not subject to expiration.